WO2011074851A3 - Préparation pharmaceutique - Google Patents

Préparation pharmaceutique Download PDF

Info

Publication number
WO2011074851A3
WO2011074851A3 PCT/KR2010/008925 KR2010008925W WO2011074851A3 WO 2011074851 A3 WO2011074851 A3 WO 2011074851A3 KR 2010008925 W KR2010008925 W KR 2010008925W WO 2011074851 A3 WO2011074851 A3 WO 2011074851A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
active ingredient
inner core
coating layer
pharmaceutical preparation
Prior art date
Application number
PCT/KR2010/008925
Other languages
English (en)
Korean (ko)
Other versions
WO2011074851A2 (fr
Inventor
이범진
풍 트란하렌
Original Assignee
㈜유라팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ㈜유라팜 filed Critical ㈜유라팜
Publication of WO2011074851A2 publication Critical patent/WO2011074851A2/fr
Publication of WO2011074851A3 publication Critical patent/WO2011074851A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une préparation pharmaceutique comprenant : un noyau interne incluant un acidulant et du bambutérol ou l'un de ses sels de qualité pharmaceutique au titre de principe actif ; et une couche de revêtement destinée au revêtement de la surface du noyau interne, la couche de revêtement incluant à la fois un polymère pH-dépendant et un polymère pH-indépendant. Lorsque la préparation selon la présente invention est administrée par voie orale, la préparation libère le principe actif après l'écoulement d'un temps de retard prédéterminé après son passage de l'estomac à l'intestin d'un patient, ce qui permet d'obtenir des effets thérapeutiques pendant la période où les symptômes asthmatiques deviennent sévères.
PCT/KR2010/008925 2009-12-14 2010-12-14 Préparation pharmaceutique WO2011074851A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0123838 2009-12-14
KR1020090123838A KR101152977B1 (ko) 2009-12-14 2009-12-14 약제학적 제제

Publications (2)

Publication Number Publication Date
WO2011074851A2 WO2011074851A2 (fr) 2011-06-23
WO2011074851A3 true WO2011074851A3 (fr) 2011-11-03

Family

ID=44167850

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/008925 WO2011074851A2 (fr) 2009-12-14 2010-12-14 Préparation pharmaceutique

Country Status (2)

Country Link
KR (1) KR101152977B1 (fr)
WO (1) WO2011074851A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103288670B (zh) * 2013-05-16 2014-11-05 南京医科大学第一附属医院 多羟基二苯甲酮衍生物及其应用
CN107668351A (zh) * 2017-10-20 2018-02-09 浙江耀飞生物科技有限公司 一种肠溶型复合饲料酸化剂

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
WO2003057278A2 (fr) * 2002-01-04 2003-07-17 Ivax Research, Inc. Systeme d'apport de medicament destine a l'apport continu de glipizide
US6635680B2 (en) * 1999-09-02 2003-10-21 Nostrum Pharmaceuticals, Inc. Controlled release pellet formulation
KR20050112599A (ko) * 2004-05-27 2005-12-01 한국화학연구원 서방형 약물 전달 시스템
KR20050114921A (ko) * 2004-06-02 2005-12-07 씨제이 주식회사 방출제어형 약제학적 조성물
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
KR20080026754A (ko) * 2006-09-21 2008-03-26 주식회사 삼양사 생물학적 활성성분을 함유하는 방출 제어형 입자, 및 이의제조방법

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6635680B2 (en) * 1999-09-02 2003-10-21 Nostrum Pharmaceuticals, Inc. Controlled release pellet formulation
WO2003057278A2 (fr) * 2002-01-04 2003-07-17 Ivax Research, Inc. Systeme d'apport de medicament destine a l'apport continu de glipizide
KR100762846B1 (ko) * 2003-09-29 2007-10-04 씨제이 주식회사 서방성 제제
KR20050112599A (ko) * 2004-05-27 2005-12-01 한국화학연구원 서방형 약물 전달 시스템
KR20050114921A (ko) * 2004-06-02 2005-12-07 씨제이 주식회사 방출제어형 약제학적 조성물
KR20080026754A (ko) * 2006-09-21 2008-03-26 주식회사 삼양사 생물학적 활성성분을 함유하는 방출 제어형 입자, 및 이의제조방법

Also Published As

Publication number Publication date
KR101152977B1 (ko) 2012-06-11
KR20110067302A (ko) 2011-06-22
WO2011074851A2 (fr) 2011-06-23

Similar Documents

Publication Publication Date Title
WO2011139044A3 (fr) Composition pharmaceutique à libération contrôlée comprenant de la tamsulosine ou des sels de tamsulosine acceptables au plan pharmaceutique, et préparation orale comportant cette composition
WO2009127974A3 (fr) Préparation pharmaceutique pour le traitement de maladies cardiovasculaires
WO2011112229A3 (fr) Préparations d'agent thérapeutique pour une administration dans une lumière du tractus intestinal à l'aide d'un dispositif d'administration de médicament avalable
JP2013540807A5 (fr)
WO2012020097A3 (fr) Utilisation de liants pour la fabrication de formulations stables à l'entreposage
WO2013012199A8 (fr) Préparation sous forme de capsule comprenant du montélukast et de la lévocétirizine
WO2015020943A3 (fr) Composition d'enzymes digestives appropriée pour une administration entérale
HRP20201316T1 (hr) Novi modulatori receptora sfingozin-fosfata
JP2012505884A5 (fr)
TN2011000307A1 (en) Galenic formulation of organic compounds
WO2010020856A3 (fr) Administration modulée de médicaments depuis un dispositif d’administration composite
JP2013508289A5 (fr)
WO2011111027A3 (fr) Formulation de comprimé oral dispersible à libération retardée
HRP20240115T1 (hr) Povećavanje bioraspoloživosti lijeka u terapiji naltreksonom
NZ594311A (en) Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration
WO2012010669A3 (fr) Médicament d'administration orale contenant un mélange de silodosine et d'un copolymère basique
WO2010090494A3 (fr) Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants
WO2011037976A3 (fr) Formulations pharmaceutiques de pramipexole
WO2013026558A3 (fr) Agent de polythérapie
WO2011093818A3 (fr) Compositions pharmaceutiques comprenant du salmétérol et du fluticasone
WO2011093815A3 (fr) Compositions pharmaceutiques comprenant du formotérol et du mométasone
WO2011074851A3 (fr) Préparation pharmaceutique
WO2011083402A3 (fr) Compositions à libération immédiate de médicaments labiles acides
WO2012063005A3 (fr) Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
WO2014001267A3 (fr) Forme galénique pour la libération de principes actifs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10837847

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10837847

Country of ref document: EP

Kind code of ref document: A2